Drug Topics

MAY 27, 2025

Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.

Community Pharmacies 432

Community Pharmacies 432

STAT

MAY 27, 2025

CAMBRIDGE, Mass. — It began, unlike any other international meeting devoted to discussions of powerful DNA-modifying technologies, with a dance. Four neon leotard-clad bodies whirled and contorted, cleaving and helixing across the stage at the American Academy of Arts and Sciences in the kinetically charged choreography of DNA strands and CRISPR enzymes caroming around a human cell.

130

130

Drug Topics

MAY 27, 2025

David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.

Community Pharmacies 363

Community Pharmacies 363

STAT

MAY 27, 2025

Mickey Mouse wishes he had the profit margins of some hospitals. AdventHealth is currently more profitable than the average company within the S&P 500. The tax-exempt, religious system, which runs 53 hospitals across nine states, generated a 17% operating margin and 23% net margin, inclusive of investments, in the first three months of 2025. Its net margin was larger than that of Amazon, ExxonMobil, and, yes, Walt Disney.

Hospitals 127

Hospitals 127

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MAY 27, 2025

Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.

Hospitals 341

Hospitals 341

pharmaphorum

MAY 27, 2025

Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance

114

114

STAT

MAY 27, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning, I hope you had a nice long weekend. I spent it working on my first (baby-sized) quilt, playing soccer, and eating lots of good food. But now it’s back to the news.

116

116

Pharmaceutical Technology

MAY 27, 2025

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.

97

97

STAT

MAY 27, 2025

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!

105

105

The FDA Law Blog

MAY 27, 2025

By Dr. Naomi Lowy, Principal Drug Regulatory Expert FDA recently announced, CEO Forums: An FDA Listening Tour to Engage Pharma CEOs. These are scheduled to take place in several cities on both coasts in June and July (Link here). This tour to engage with pharmaceutical and biotech CEOs is unprecedented. According to the announcement, Commissioner Makary will be holding these along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDAs Center for Biologics Evaluation a

FDA 110

FDA 110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 27, 2025

It’s easy to feel as though you’re doing something wrong these days if you don’t know your VO 2 -Max and how many hours of REM sleep you get each night, or if you’re not taking a dozen different supplements and scrutinizing every morsel of food that makes its way into your mouth. “Biohackers” and other longevity seekers — with their many podcasts, YouTube channels, and X accounts — would have you believe that if you diligently measure your

139

139

Pharmacy Times

MAY 27, 2025

Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 variant that has become dominant in the US.

Vaccines 97

Vaccines FDA 97

STAT

MAY 27, 2025

This is the online version of STAT’s weekly email newsletter Health Care Inc.  Sign up here. We’re back on this Tuesday — hope you had a good Memorial Day weekend! This Friday at 10:55 a.m. ET, I’ll be participating (virtually) on a panel run by the National Academies of Sciences, Engineering, and Medicine. We’ll be talking about all things Medicare Advantage.

Hospitals 100

Hospitals Insurance Documentation 100

Pharmacy Times

MAY 27, 2025

In this roundtable, 3 pharmacy faculty members reflect on how shifting federal priorities and the defunding of research initiatives have impacted their work, communities, and careerswhile highlighting the power of resilience, solidarity, and reimagined academic impact in advancing public health equity.

86

86

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

MAY 27, 2025

For the second year running, data at ASCO on Merus' bispecific antibody petosemtamab in head and neck cancer has drawn the eye

66

66

Pharma Marketing Network

MAY 27, 2025

In an era where digital voices influence everything from fashion to finance, its natural to ask: does influencer marketing work in pharma? Traditionally conservative and heavily regulated, the pharmaceutical industry is now exploring new ways to connect with patients, caregivers, and healthcare professionals. As consumer behavior continues to shift online, pharma marketers are evaluating whether social influencers can play a trusted role in driving engagement, education, and even brand loyalty.

FDA 59

FDA Communication 59

pharmaphorum

MAY 27, 2025

Recent breakthroughs in 3D bioprinting: A look at trends and challenges Nicole.

59

59

Hospital Pharmacy Europe

MAY 27, 2025

Patients gender, age and ethnicity significantly influence the likelihood of having a medication-related error formally reported, according to a cross-sectional study by Barts Health NHS Trust in London, UK. The findings of this first report assessing possible disparities in medicine-related incident reporting in England highlight that systematic support is required to reduce the variation of medicine error reporting among patients with key protected characteristics.

Compounding 52

Compounding Hospitals 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

MAY 27, 2025

As a blood thinner or anticoagulant, Xarelto plays a pivotal role in preventing stroke in atrial fibrillation. Known as AFib, this condition is the most prevalent heart rhythm problem requiring treatment. The atria or top chambers of the heart beat erratically rather than rhythmically, and as a result, the ventricles or bottom pumping chambers beat erratically too.

Labelling 52

Labelling FDA 52

Blog: Ask a Student Pharmacist

MAY 27, 2025

Jamie Chen: Chemistry and connection within pharmacy eomizowh Tue, 05/27/2025 - 09:39 Author: Erin Wilson Second-year PharmD student Jamie Chens love for chemistry and human connection led her north to the University of Minnesota College of Pharmacy. While pursuing her undergraduate degree in chemistry, she shadowed pharmacists at an independent pharmacy in Arkansas, her home state, keeping the experience in her back pocket as she explored her options.

Independent Pharmacies 52

Independent Pharmacies 52

Pharmaceutical Technology

MAY 27, 2025

Upperton Pharma Solutions is a winner in the Business Expansion category in the 2025 Pharmaceutical Excellence Awards.

59

59

Pharmafile

MAY 27, 2025

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciencesand pharmaceutical marketing agency with responsibility for managing campaign delivery across international digital and in-person projects. In her new role, Darcy will serve as the main point of contact for key pharmaceutical services clients, supporting the […] The post Orientation Marketing appoints Sarah Darcy as sales operations executi

59

59

Pharmaceutical Technology

MAY 27, 2025

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

52

52

Compounding Pharmacy of America

MAY 27, 2025

Discover how compounded medications offer custom support for diabetes, neuropathy, and hormone balance. Tailored care for better results. The post Diabetes and Compounded Medications: A Personalized Approach to Chronic Care appeared first on Compounding Pharmacy of America.

Compounding 52

Compounding Compounding Pharmacies 52

Pharmaceutical Technology

MAY 27, 2025

GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific conditions.

52

52

Pharmafile

MAY 27, 2025

The Royal Marsden, a world-leading cancer research centre, has launched a large-scale, AI-powered radiology platform designed to accelerate cancer detection and treatment using medical imaging. This marks a major milestone in the application of AI for cancer research. The technology will develop and evaluate AI algorithms to improve the accuracy of cancer evaluation, including sarcoma, […] The post The Royal Marsden launches AI radiology platform to revolutionise cancer care appeared first

64

64

European Pharmaceutical Review

MAY 27, 2025

The Committee for Medicinal Products for Human Use (CHMP) has recommended ten medicines for approval in its latest meeting. The committee recommended authorisation of three cancer medicines. The first, aconditional approval of Aucatzyl (obecabtagene autoleucel), to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia. Blenrep (belantamab mafodotin), a treatment for relapsed or refractory multiple myeloma was also granted a positive opinion.

Generic Medicine 59

Generic Medicine 59

Pharmaceutical Technology

MAY 27, 2025

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.

52

52

pharmaphorum

MAY 27, 2025

Despite a voluntary admission of a breach of the ABPI code, Sanofi is deemed to have "brought discredit" on the pharma industry

59

59

Pharma Tutor

MAY 27, 2025

Does India need five years for the B.Pharm course? Rajesh Vagh Tue, 05/27/2025 - 17:05 In recent days, there has been growing discussion and a few articles advocating for the extension of the Bachelor of Pharmacy (B.Pharm) program in India from four years to five years. These calls are often based on the intent to strengthen the academic depth of the course, enhance clinical exposure, and align Indian pharmacy education with global standards.

40

40

pharmaphorum

MAY 27, 2025

The Royal Marsden NHS Foundation Trust has joined forces with two private-sector companies on AI models to detect cancer and guide treatment choices

59

59

Therapeutics Education Collaboration

MAY 27, 2025

THE CASE Dr Ashville is training to be a family physician and gets a phone call from a disgruntled patient called Jane Brown. She got a message saying As your Cardiovascular risk is now 10% it is recommended you take a statin medication. She is a bit cross she didnt get a proper conversation about a new prescription but her main question isHow likely am I to actually benefit from this treatment?

40

40

Fierce Healthcare

MAY 27, 2025

CMS provided an update on the status of the Kidney Care Choices Model on Monday, choosing to largely extend the model for an additional year.

58

58